SHAWN GARCIA: Open Payments
NPI 1306142906 · BROOKLYN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,826 in 187 payments from 26 companies in 2025. Trend: 2023 $1,402 · 2024 $1,901 · 2025 $2,826
Food & beverage: $2,826
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 43 | $469 |
| Otsuka America Pharmaceutical, Inc. | 21 | $370 |
| Vanda Pharmaceuticals Inc. | 11 | $275 |
| Novo Nordisk Inc | 20 | $270 |
| Axsome Therapeutics, Inc. | 6 | $219 |
| Kowa Pharmaceuticals America, Inc. | 25 | $178 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 16 | $138 |
| Lundbeck LLC | 4 | $108 |
| Neurocrine BioSciences, Inc. | 5 | $98 |
| GlaxoSmithKline, LLC. | 4 | $84 |
Products named: REXULTI, VRAYLAR, Ozempic, Auvelity, HETLIOZ, ZORYVE, CAPLYTA, INGREZZA.
Industry payments across NY — which companies pay providers there.
